Britain could use its national interest powers to veto US pharmaceutical manufacturer Pfizer’s £63bn bid for UK-based AstraZeneca, business secretary Vince Cable has said.
UK law states any deal can be vetoed if deemed not to be in the national interest, as concerns mount that the country could be used by the American Pfizer as a tax haven as it seeks to create the world’s largest pharmaceutical company. As the takeover saga intensifies with MPs questioning the business secretary…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
